Contraception News and Research

Latest Contraception News and Research

Biden’s ‘incremental’ health plan still would be a heavy lift

The headlines about presidential candidate Joe Biden's new health care plan called it "a nod to the past" and "Affordable Care Act 2.0."

22 Jul 2019

Menstrual cups just as good as sanitary pads or tampons

A new study has shown that menstrual cups are a safe, effective and inexpensive way to deal with menstrual blood flow. The report covered 43 studies and more than 3,300 females. The study titled, 'Menstrual cup use, leakage, acceptability, safety, and availability: a systematic review and meta-analysis, is published in the Lancet Public Health.

18 Jul 2019

Study explores pregnancy-related adverse events associated with acne medication

Isotretinoin (also known by its former brand name as Accutane or Roaccutane) is an extremely effective acne medication that can help patients whose severe acne has not responded to other drugs.

17 Jul 2019

KHN’s ‘What the Health?’: Could the ACA really go away?

The Affordable Care Act was back in court again this week — this time before a three-judge panel at the 5th Circuit Court of Appeals in New Orleans.

11 Jul 2019

$FDA grants accelerated approval to new treatment for refractory multiple myeloma$

FDA grants accelerated approval to new treatment for refractory multiple myeloma

Today, the U.S. Food and Drug Administration granted accelerated approval to Xpovio (selinexor) tablets in combination with the corticosteroid dexamethasone for the treatment of adult patients with relapsed refractory multiple myeloma who have received at least four prior therapies and whose disease is resistant to several other forms of treatment, including at least two proteasome inhibitors, at least two immunomodulatory agents, and an anti-CD38 monoclonal antibody.

3 Jul 2019

Long-acting contraceptives do not increase risk of HIV, concludes new study

One of the largest and most robust studies on HIV infection rates has concluded that long-acting contraceptives do not increase the risk of contracting HIV.

14 Jun 2019

AMA adopts new policies aimed at improving health of the nation

The American Medical Association, the premier national physician organization in the country, voted this week to adopt new policies aimed at improving the health of the nation.

14 Jun 2019

KHN’s ‘What the Health’: Who will pay to fix problem of surprise medical bills?

Congress is finally getting down to real work on legislation to end "surprise" medical bills, which patients get if they inadvertently receive care from an out-of-network health providers or use one in an emergency.

13 Jun 2019

First chemoimmunotherapy regimen approved by FDA for patients with diffuse large B-cell lymphoma

Today, the U.S. Food and Drug Administration granted accelerated approval to Polivy (polatuzumab vedotin-piiq), in combination with the chemotherapy bendamustine and a rituximab product (a combination known as "BR"), to treat adult patients with diffuse large B-cell lymphoma (DLBCL) that has progressed or returned after at least two prior therapies.

10 Jun 2019

Podcast: KHN’s ‘What the Health?’ The state of the abortion debate — a deep dive

Abortion is one of the hottest political issues of 2019. With a newly configured Supreme Court, which many pundits think has the votes to roll back or overturn the landmark 1972 Roe v. Wade ruling, states are rushing either to protect abortion rights or pass laws intended to restrict or ban it.

30 May 2019

UCSF Medical Center backs off plan to deepen ties with Dignity Health

UCSF Medical Center officials said Tuesday they no longer would pursue a formal affiliation with Dignity Health, a large Catholic health care system that restricts care on the basis of religious doctrine.

28 May 2019

Podcast: KHN’s ‘What the Health?’ Is ‘Medicare for All’ losing steam?

A second House committee this week held a hearing on proposals for a single-payer health system, such as “Medicare for All,” featuring experts from the Congressional Budget Office.

23 May 2019

LC-MS/MS test for progesterone outperforms traditional immunoassays

Researchers have devised a cheap, non-invasive and specific means to monitor progesterone production in women.

15 May 2019

Oral contraceptives may reduce risk of ACL tears in women

Oral contraceptives may lower the risk of anterior cruciate ligament tears in women, according to a large observational study involving over 165,000 female patients (aged 15-49), published in The Physician and Sports medicine journal.

30 Apr 2019

Will ties to a Catholic hospital system tie doctors’ hands?

As Catholic health care systems across the country expand, the University of California's flagship San Francisco hospital has become the latest arena for an emotional debate: Should the famously progressive medical center increase its treatment space by joining forces with a Catholic-run system that restricts care according to religious doctrine?

29 Apr 2019

Podcast: KHN’s ‘What the Health?’ The abortion wars rage on

A federal district judge in Oregon blocked new rules for the federal family planning program issued by the Trump administration and due to take effect May 3. It's one of several cases out to thwart the changes that would effectively evict Planned Parenthood from the Title X program.

25 Apr 2019

Study explores factors that impact fertility preservation decisions in transgender youth

The last thing on most teens' minds is whether or not they want to have kids someday. But transitioning transgender adolescents are forced to consider whether to preserve their sperm or eggs at a young age.

16 Apr 2019

FDA approves new treatment for adults with metastatic bladder cancer

The U.S. Food and Drug Administration today granted accelerated approval to Balversa (erdafitinib), a treatment for adult patients with locally advanced or metastatic bladder cancer that has a type of susceptible genetic alteration known as FGFR3 or FGFR2, and that has progressed during or following prior platinum-containing chemotherapy.

12 Apr 2019

Unisex, hormone-free contraceptive pill on the horizon

Side effects from hormonal contraceptives are common. That’s why one start-up is developing a hormone-free contraceptive that can be used by both men and women.

12 Apr 2019

FDA extends indication of metastatic breast cancer treatment to include male patients

The U.S. Food and Drug Administration today is extending the indication of Ibrance (palbociclib) capsules in combination with specific endocrine therapies for hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in male patients.

5 Apr 2019

Contraception News and Research

Latest Contraception News and Research

Biden’s ‘incremental’ health plan still would be a heavy lift

Menstrual cups just as good as sanitary pads or tampons

Study explores pregnancy-related adverse events associated with acne medication

KHN’s ‘What the Health?’: Could the ACA really go away?

FDA grants accelerated approval to new treatment for refractory multiple myeloma

Long-acting contraceptives do not increase risk of HIV, concludes new study

AMA adopts new policies aimed at improving health of the nation

KHN’s ‘What the Health’: Who will pay to fix problem of surprise medical bills?

First chemoimmunotherapy regimen approved by FDA for patients with diffuse large B-cell lymphoma

Podcast: KHN’s ‘What the Health?’ The state of the abortion debate — a deep dive

UCSF Medical Center backs off plan to deepen ties with Dignity Health

Podcast: KHN’s ‘What the Health?’ Is ‘Medicare for All’ losing steam?

LC-MS/MS test for progesterone outperforms traditional immunoassays

Oral contraceptives may reduce risk of ACL tears in women

Will ties to a Catholic hospital system tie doctors’ hands?

Podcast: KHN’s ‘What the Health?’ The abortion wars rage on

Study explores factors that impact fertility preservation decisions in transgender youth

FDA approves new treatment for adults with metastatic bladder cancer

Unisex, hormone-free contraceptive pill on the horizon

FDA extends indication of metastatic breast cancer treatment to include male patients

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Contraception News and Research

Latest Contraception News and Research

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Newsletters you may be interested in